Skip to main content

Oxytrol for Women FDA Approval History

FDA Approved: Yes (First approved January 25, 2013)
Brand name: Oxytrol for Women
Generic name: oxybutynin
Dosage form: Transdermal System
Company: Merck
Treatment for: Overactive Bladder

Oxytrol for Women (oxybutynin) is a muscarinic receptor antagonist transdermal patch available over-the-counter for the treatment of overactive bladder in women.

Development timeline for Oxytrol for Women

Jan 25, 2013Approval FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.